Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Because differentiated (follicular and papillary) thyroid cancer (DTC) may recur years after initial treatment, the follow-up of patients with DTC is long term. However, this population has changed, with more individuals being discovered at an earlier stage of the disease, so that previous follow-up protocols based mostly on data from high-risk patients no longer apply. We sought to develop an improved protocol for the follow-up of low-risk patients with DTC based on the findings of recent studies. METHODS: We analysed recent literature on the follow-up of DTC. RESULTS: Recent large studies have produced three important findings: (i) in patients with low-risk DTC with no evidence of disease up to the 6- to 12-month follow-up, diagnostic whole-body scan adds no information when serum thyroglobulin (Tg) is undetectable and interference from anti-Tg antibodies is absent; (ii) use of recombinant human thyroid-stimulating hormone to aid Tg measurement is effective and provides greater safety, quality-of-life and work productivity than does levothyroxine withdrawal with its attendant hypothyroidism; and (iii) ultrasonography performed by an experienced operator is the most sensitive means of detecting neck recurrences of DTC. CONCLUSIONS: We present a revised follow-up protocol for low-risk patients taking into account the above findings. This protocol should help clinicians enter a new era of monitoring characterized by greater safety, simplicity, convenience and cost savings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Papillary and Follicular Thyroid Carcinoma
Schlumberger, M. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380506 · Cited by 1,623
Self-citationMazzaferri, E. L., Robbins, R. J., Spencer, C. A., Braverman, L. E., Pacini, F., Wartofsky, L., Haugen, B. R., Sherman, S. I., Cooper, D. S., Braunstein, G. D., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021702 · Cited by 654
Self-citationHaugen, B. R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P. W., Sherman, S. I., Cooper, D. S., Graham, K. E., Braverman, L. E., Skarulis, M. C., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6094 · Cited by 566
Self-citationSchlumberger, M. J., Vathaire, C. C.-D., de Vathaire, F., Travagli, J. P., Gardet, P., Lumbroso, J., Francese, C., Fontaine, F., Ricard, M., & Parmentier, C. (1996) · PubMed · Cited by 498
Self-citationLadenson, P. W., Braverman, L. E., Mazzaferri, E. L., Brucker-Davis, F., Cooper, D. S., Garber, J. R., Wondisford, F. E., Davies, T. F., DeGroot, L. J., Daniels, G. H., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371304 · Cited by 466
Spencer, C. A., Takeuchi, M., Kazarosyan, M., Wang, C. C., Guttler, R. B., Singer, P. A., Fatemi, S., LoPresti, J. S., & Nicoloff, J. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4683 · Cited by 456
Effects of Subclinical Thyroid Dysfunction on the Heart
Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-11-200212030-00011 · Cited by 445
Pacini, F., Molinaro, E., Castagna, M. G., Agate, L., Elisei, R., Ceccarelli, C., Lippi, F., Taddei, D., Grasso, L., & Pinchera, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021925 · Cited by 428
Self-citationDisappearance of Humoral Thyroid Autoimmunity after Complete Removal of Thyroid Antigens
Chiovato, L., Latrofa, F., Braverman, L. E., Pacini, F., Capezzone, M., Masserini, L., Grasso, L., & Pinchera, A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00010 · Cited by 364
Self-citationCailleux, A. F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.175 · Cited by 357
Pacini, F. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1499 · Cited by 299
Self-citationQuality-of-Life Changes in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone Therapy
DOW, K. H., FERRELL, B. R., & ANELLO, C. (1997) · Thyroid · doi:10.1089/thy.1997.7.613 · Cited by 289
Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma
Frasoldati, A., Pesenti, M., Gallo, M., Caroggio, A., Salvo, D., & Valcavi, R. (2003) · Cancer · doi:10.1002/cncr.11031 · Cited by 289
Pacini, F. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.6.1401 · Cited by 285
Self-citationBaudin, E., Cao, C. D., Cailleux, A. F., Leboulleux, S., Travagli, J. P., & Schlumberger, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021365 · Cited by 278
Self-citationPacini, F. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4092 · Cited by 268
Self-citationMazzaferri, E. L. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1490 · Cited by 262
Meier, C. A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.1.188 · Cited by 257
Early Diagnosis by Genetic Analysis of Differentiated Thyroid Cancer Metastases in Small Lymph Nodes
Arturi, F. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.5.1638 · Cited by 195
Pacini, F. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5686 · Cited by 185
Self-citationIncidence of thyroid cancer in adults recorded by French cancer registries (1978–1997)
Colonna, M., Grosclaude, P., Remontet, L., Schvartz, C., Mace-Lesech, J., Velten, M., Guizard, A. V., Tretarre, B., Buemi, A., Arveux, P., et al. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00110-7 · Cited by 178
Bachelot, A., Cailleux, A. F., Klain, M., Baudin, E., Ricard, M., Bellon, N., Caillou, B., Travagli, J. P., & Schlumberger, M. (2002) · Thyroid · doi:10.1089/105072502760258686 · Cited by 169
Self-citationTorlontano, M., Crocetti, U., D’Aloiso, L., Bonfitto, N., Giorgio, A. D., Modoni, S., Valle, G., Frusciante, V., Bisceglia, M., Filetti, S., et al. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480019 · Cited by 148
Self-citationLuster, M., Laßmann, M., Haenscheid, H., Michalowski, U., Incerti, C., & Reiners, C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6903 · Cited by 113
Self-citationLippi, F., Capezzone, M., Angelini, F., Taddei, D., Molinaro, E., Pinchera, A., & Pacini, F. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440005 · Cited by 113
Self-citationSelf-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I
Hilditch, T., Dempsey, M. F., Bolster, A. A., McMenemin, R. M., & Reed, N. S. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0785-6 · Cited by 107
Haugen, B. R., Ridgway, E. C., McLaughlin, B. A., & McDermott, M. T. (2002) · Thyroid · doi:10.1089/105072502753451959 · Cited by 98
Iodine Supplementation in Austria: Methods and Results
Lind, P., Kumnig, G., Heinisch, M., Igerc, I., Mikosch, P., Gallowitsch, H. J., Kresnik, E., Gómez, I., UNTERWEGER, O., & Aigner, H. (2002) · Thyroid · doi:10.1089/105072502761016539 · Cited by 89
Self-citationBerg, G. E. B., Lindstedt, G., Suurküla, M. B., & Jansson, S. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03343960 · Cited by 86
Self-citationTurska, M., Jarząb, B., Handkiewicz-Junak, D., Roskosz, J., Puch, Z., Wygoda, Z., Kukulska, A., Jurecka‐Lubieniecka, B., Hasse-Lazar, K., & Zajusz, A. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1190-5 · Cited by 85
Wartofsky, L. (2002) · Thyroid · doi:10.1089/105072502320288438 · Cited by 83
BARTALENA, L., MARTINO, E., PACCHIAROTTI, A., GRASSO, L., AGHINI-LOMBARDI, F., BURATTI, L., BAMBINI, G., BRECCIA, M., & PINCHERA, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-849 · Cited by 65
David, A., Blotta, A., Bondanelli, M., Rossi, R., Roti, E., Braverman, L. E., Busutti, L., & Uberti, E. C. D. (2001) · PubMed · Cited by 64
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Self-citationCooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
“Following RAI ablation, when the posttherapy scan does not reveal uptake outside the thyroid bed, subsequent DxWBS have low sensitivity and are usually not necessary in low-risk patients who are clinically free of residual tumor and have an undetectable serum Tg level on thyroid hormone and negative cervical US (197,2…”
Self-citationCooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Sherman, S. I., & Tuttle, R. M. (2006) · Thyroid · doi:10.1089/thy.2006.16.109 · Cited by 2,016
Pacini, F., Schlumberger, M., Dralle, H., Elisei, R., Smit, J. W. A., Wiersinga, W., & _, _. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02158 · Cited by 1,976
Self-citationGuidelines for the management of thyroid cancer
Perros, P., Boelaert, K., Colley, S., Evans, C., Evans, R. M., Gerrard BA, G., Gilbert, J., Harrison, B., Johnson, S. J., Giles, T. E., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12515 · Cited by 1,372
Metadata
- Authors
- Schlumberger, M., Berg, G., Cohen, O., Duntas, L., Jamar, F., Jarzab, B., Limbert, E., Lind, P., Pacini, F., Reiners, C., Sanchez Franco, F., Toft, A., & Wiersinga, W.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02-01
- Volume
- 150
- Issue
- 2
- Pages
- 105-112
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2142563702
- Cited by
- 327
- References
- 34
- FWCI
- 25.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.